¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ´ç´¢º´ÇÐȸ 2018 International Congress of Diabetes and Metabolism : 2018-10-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ´ç´¢º´ÇÐȸ 2018 International Congress of Diabetes and Metabolism : 2018-10-12
±³À°ÀÏÀÚ : 2018-10-12
±³À°Àå¼Ò : ±×·£µåÈúÆ°¼­¿ïÈ£ÅÚ  
±³À°ÁÖÁ¦ : 2018 International Congress of Diabetes and Metabolism      
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : ÀÌ¿¬ÁÖ
¿¬¶ôó : 02-714-9074  
À̸ÞÀÏ : diabetes@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 350,000¿ø      
ºñ°í On-site Regular rate full Registration: USD 350Early Regular rate full Registration: USD 250On-site Reduced rate full Registration: USD 180Early Reduced rate full Registration: USD 125      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 12ÀÏ Convention hall A 09:00~09:25 Preventing serious health consequences of type 2 diabetes - the evidence  Hertzel C. Gerstein(McMaster University, Canada) 
±³À°½Ã°£ 10¿ù 12ÀÏ Convention hall A 09:25~09:50 Dyslipidemia  Sung Hee Choi(Seoul National University, Korea) 
±³À°½Ã°£ 10¿ù 12ÀÏ Convention hall A 09:50~10:15 Update on current trends in hypertension  Joong-Wha Chung(Chosun University, Korea) 
±³À°½Ã°£ 10¿ù 12ÀÏ Convention hall A 10:15~10:40 Anti-platelet therapy  Young-Hoon Jeong(Gyeongsang National University, Korea) 
±³À°½Ã°£ 10¿ù 12ÀÏ Convention hall A, B, C 11:10~11:50 Novel class of signaling lipids with beneficial metabolic effects  Barbara B. Kahn(Harvard University, USA) 
±³À°½Ã°£ 10¿ù 12ÀÏ Convention hall A 12:10~13:20 DECLARE-TIMI 58: participants  Ofri Mosenzon(Hadassah Hebrew University, Israel) 
±³À°½Ã°£ 10¿ù 12ÀÏ Convention hall A 13:20~13:50 TZD¡¯s benefits and side effects and about the new PPAR enhancing agents to avoid those side effects  Toshimasa Yamauchi(University of Tokyo, Japan) 
±³À°½Ã°£ 10¿ù 12ÀÏ Convention hall A 13:50~14:20 Benefit and harm of anti-diabetic agent: DPP4 inhibitors  Mark E Cooper(Monash University, Australia) 
±³À°½Ã°£ 10¿ù 12ÀÏ Convention hall A 14:20~14:50 GLP1 RA  Paolo Pozzilli(University Campus Bio-Medico, Italy) 
±³À°½Ã°£ 10¿ù 12ÀÏ Convention hall A 14:50~15:20 SGLT2 inhibitor  Ofri Mosenzon(Hadassah Hebrew University, Israel) 
±³À°½Ã°£ 10¿ù 12ÀÏ Emerald hall A 16:20~16:45 Regulation of skeletal muscle mitochondrial biogenesis and functions  K . Sreekumaran Nair(Mayo Clinic, USA) 
±³À°½Ã°£ 10¿ù 12ÀÏ Emerald hall A 16:45~17:10 Effect of hypothalamic leptin resistance on energy metabolism in skeletal muscle  Dae-Kyu Song(Keimyung University, Korea) 
±³À°½Ã°£ 10¿ù 12ÀÏ Emerald hall A 17:10~17:35 Skeletal muscle as a therapeutic target for diabetes  Cheol Soo Choi(Gachon University, Korea) 
±³À°½Ã°£ 10¿ù 12ÀÏ Emerald hall A 17:35~18:00 Advances in understanding skeletal muscle insulin sensitivity across the lifespan  Melanie Cree-Green(University of Colorado, USA) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ´ç´¢º´ÇÐȸ 2018 International Congress of Diabetes and Metabolism : 2018-10-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °­³²¼¼ºê¶õ½ºº´¿ø The 6th GSTEC (Gangnam Severance Single Topic Endoscopic Conference) : 2018-10-13
´ÙÀ½±Û 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ½ÉÈ­±³À°(»çÀüµî·Ï Çʼö) : 2018-10-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20790 °æ±â ´ëÇÑÇǺΰúÇÐȸ Á¦52Â÷ ÀÎõºÎõÁöºÎȸ ÇмúÁý´ãȸ : 2024-06-15 0 9 2024-05-27
20789 ¼­¿ï 2024³â ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ¿¬¼ö°­Á : 2024-06-15 0 7 2024-05-27
20788 Á¦ÁÖ ´ëÇѳ»ºÐºñÇÐȸ Á¦22ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-15 0 10 2024-05-27
20787 Ãæ³² (¿Â¶óÀÎ)2024³âµµ Ãæû³²µµÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 8 2024-05-27
20786 ºÎ»ê KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2024-06-14 0 6 2024-05-27
20785 ¼­¿ï 2024³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (´Ù½Ã, °Ü¿ï³ª¹«¿¡¼­ º½ ³ª¹«¿¡·Î From Traditional approaches to Innovation in Psychiatry) : 2024-06-14 0 7 2024-05-27
20784 ¼­¿ï ´ëÇÑ°áÇÙÇùȸ 2024³â °áÇÙ°ü¸®±³À° 1±â(2ÀÏÂ÷) : 2024-06-14 0 5 2024-05-27
20783 ¼­¿ï Á¦14Â÷ Çѱ¹ÃÖ¼Òħ½ÀÃéÀå¼ö¼ú¿¬±¸È¸ : 2024-06-14 0 5 2024-05-27
20782 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç (2ÀÏÂ÷) : 2024-06-14 0 7 2024-05-27
20781 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø RARE DISEASE SYMPOSIUM 2024 : 2024-06-14 0 2 2024-05-27
20780 ºÎ»ê 2024 ´ëÇѽŰæ¿Ü°úÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦2Â÷ Á¤±âÇмú´ëȸ : 2024-06-14 0 12 2024-05-27
20779 ¼­¿ï 2024 ´ëÇÑÀÇÇÐȸ Çмú´ëȸ : 2024-06-14 0 7 2024-05-27
20778 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14 0 8 2024-05-27
20777 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-14 0 8 2024-05-27
20776 ºÎ»ê 2024³â Çѱ¹°£´ãÃé¿Ü°úÇÐȸ ºÎ¿ï°æÁöȸ °£ÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-14 0 7 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷